MedAdvisor (ASX:MDR) says it expects its 1H FY23 revenue to be up 50-60% on 1H FY22, between $58M - $61M.

MedAdvisor says its US digital strategy is gaining momentum with the expansion of the COVID-19 awareness program combined with increased pharmacy participation in the US platform, inMotion.

MedAdvisor?s Managing Director and CEO Rick Ratliff says the increase is thanks to the number of community pharmacies enabling digital access to 60 million individuals:

?As the US deals with health issues related to the flu, RSV, and COVID-19, pharmaceutical companies are driving more vaccination awareness and education programs.?